AORT
What one share of Artivion holds
Surgical and Medical Instruments and Apparatus
Artivion, Inc. (“Artivion,” the “Company,” “we,” or “us”), is a leader in the manufacturing, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease.
Artivion’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $9.61 |
|---|---|
| Profit | −$0.06 |
| Capex (buildings and equipment) | $1.04 |
| Free cash flow | −$0.19 |
| Cash and investments | $1.59 |
| Debt | $7.53 |
| Book value | $9.14 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2016 | $5.50 | $0.32 | $0.19 | $0.41 | $0.00 | $6.34 |
| 2017 | $5.55 | $0.11 | $0.19 | $0.12 | $0.00 | $7.59 |
| 2018 | $7.22 | −$0.08 | $0.16 | $0.11 | $0.00 | $7.43 |
| 2019 | $7.30 | $0.05 | $0.21 | $0.20 | $0.00 | $7.31 |
| 2020 | $6.69 | −$0.44 | $0.19 | $0.13 | — | $8.44 |
| 2021 | $7.67 | −$0.38 | $0.34 | −$0.40 | — | $7.50 |
| 2022 | $7.84 | −$0.48 | $0.27 | −$0.40 | — | $6.80 |
| 2023 | $8.69 | −$0.75 | $0.24 | $0.22 | — | $6.84 |
| 2024 | $9.32 | −$0.32 | $0.27 | $0.27 | — | $6.57 |
| 2025 | $9.36 | $0.21 | $0.83 | $0.02 | — | $9.36 |